Ad
related to: ANGIODYNAMICS, INC
Search results
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 weeks agoAngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript April 4, 2024 AngioDynamics, Inc....
AngioDynamics (ANGO) Settles Patent Litigations With BD
Zacks via Yahoo Finance· 3 weeks agoAngioDynamics (ANGO) announces its settlement agreement with BD's affiliate, C.R. Bard, to resolve a...
AngioDynamics (ANGO) Q1 Earnings, Revenues Lag Estimates
Zacks via Yahoo Finance· 2 years agoAngioDynamics, Inc. ANGO reported an adjusted loss per share of 6 cents for first-quarter fiscal...
AngioDynamics (ANGO) Q4 Earnings in Line, Revenues Beat Mark
Zacks via Yahoo Finance· 2 years agoAngioDynamics, Inc. ANGO reported adjusted earnings per share (“EPS”) of a penny for fourth-quarter...
AngioDynamics (ANGO) Q2 Earnings Top Estimates, Revenues Miss
Zacks via Yahoo Finance· 4 months agoAngioDynamics, Inc. ANGO reported an adjusted loss per share of 5 cents for second-quarter fiscal...
AngioDynamics (ANGO) Divests Its PICC & Midline Businesses
Zacks via Yahoo Finance· 2 months agoAngioDynamics (ANGO) finalizes its PICC and Midline businesses divestment to Spectrum Vascular to...
AngioDynamics (ANGO) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 10 months agoAngioDynamics, Inc. ANGO is scheduled to release fourth-quarter fiscal 2023 results on Jul 12,...
AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment
Zacks via Yahoo Finance· 3 weeks agoAngioDynamics (ANGO) announces the FDA's approval of its AlphaVac F1885 System, which is likely to...
Shareholders May Be A Bit More Conservative With AngioDynamics, Inc.'s (NASDAQ:ANGO) CEO...
Simply Wall St. via Yahoo Finance· 1 year agoIn the past three years, shareholders of AngioDynamics, Inc. (NASDAQ:ANGO) have seen a loss on their...
AngioDynamics' (ANGO) New FDA Recognition to Boost Treatment
Zacks via Yahoo Finance· 8 months agoThe FDA's grant of the Breakthrough Device designation for AngioDynamics' (ANGO) AngioVac is likely...
